Digoxin antibody decreases natriuresis and diuresis in cerebral hemorrhage-Reference-Cited by-同舟云学术

Digoxin antibody decreases natriuresis and diuresis in cerebral hemorrhage

Published:2003-09-03 Issue:12 Volume:29 Page:2291-2296
ISSN:0342-4642
Container-title:Intensive Care Medicine
language:en
Short-container-title:Intensive Care Med

Author:

Menezes João C.,Troster Eduardo J.,Dichtchekenian Varujan

Publisher

Springer Science and Business Media LLC

Subject

Critical Care and Intensive Care Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00134-003-1955-0.pdf

Reference26 articles.

1. Harrigan MR (2001) Cerebral salt wasting syndrome. Crit Care Clin 17:125–138

2. Palmer BF (2000) Hyponatremia in a neurosurgical patient: syndrome of inappropriate antidiuretic hormone secretion versus cerebral salt wasting. Nephrol Dial Transplant 15:262–268

3. Schwartz WB, Bennett W, Curelop S, Bartter FC (1957) A syndrome of renal salt loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am J Med 13:529–542

4. Miller M (2001) Syndromes of excess antidiuretic hormone release. Crit Care Clin 17:11–23

5. Peters JP, Welt LG, Sims EAH, Orloff J, Needham J (1950) Salt-wasting syndrome associated with cerebral disease. Trans Assoc Am Physicians 63:57–64

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody against Na/K-ATPase Inhibitor Lowers Blood Pressure and Increases Vascular Fli1 in Experimental Preeclampsia;American Journal of Hypertension;2019-11-12

2. Microglia-derived TNF-α mediates endothelial necroptosis aggravating blood brain–barrier disruption after ischemic stroke;Cell Death & Disease;2019-06-20

3. The pump, the exchanger, and the holy spirit: origins and 40-year evolution of ideas about the ouabain-Na+pump endocrine system;American Journal of Physiology-Cell Physiology;2018-01-01

4. DigiFab Interacts With Endogenous Cardiotonic Steroids and Reverses Preeclampsia-Induced Na/K-ATPase Inhibition;Reproductive Sciences;2012-05-30

5. Endogenous Cardiotonic Steroids: Physiology, Pharmacology, and Novel Therapeutic Targets;Pharmacological Reviews;2009-03